Ex Parte Wolffe et al - Page 4




            Appeal No. 2006-2851                                                                              
            Application No. 09/844,501                                                                        
            and several restriction enzyme digests of DNaseI digested HEL nuclei.   The data                  
            summarized in FIG. 2 (A-D) show that there is a single DNaseI hypersensitive site                 
            between the 2.3 kb BgIII fragment and the 2.4 kb HindIII fragment . . .”   Column 8, lines        
            48-51.   Accordingly, Grosveld obtained fragments of the adult β-globin gene and                  
            probed these fragments to locate the DNaseI hypersensitive site.   Grosveld did not,              
            according to claim 123, step (e), contact the DNA fragments obtained in step (d) with a           
            population of vector molecules, wherein the vector molecules comprise a first end that is         
            compatible with the first enzyme and a second end that is compatible with the second              
            enzyme, under conditions favorable to ligation of compatible ends; or step (f), select            
            polynucleotides comprising a DNA fragment ligated to a vector molecule.  Grosveld, on             
            the other hand, probed DNA fragments which were not ligated to a vector, and selected             
            the DNA fragment of interest having the DNaseI hypersensitive site by its ability to bind         
            to a probe.                                                                                       
                   In a different experiment, Grosveld incorporated the previously identified DNAse I         
            hypersensitive sites into a vector or plasmid containing both the hypersensitive sites            
            and the adult β-globin gene.  Column 15, lines 6-47.   The DNA fragments cloned in the            
            experiment described in column 15 are not the same as the fragments described in                  
            column 8.  In particular, the hypersensitive site (HSS)-containing fragments cloned in            
            col. 15 are not the DNAse/I restriction enzyme fragments from col. 8.  See col. 15, lines         
            45-46: PvuI-BstEII fragment with HSS 1 and 2; BstEII-ClaI fragment with HSS 3 and 4.              
                   In contrast, appellants describe their method in the specification, pages 49-50, as        

                                                      4                                                       





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007